Parkinson's Disease and Sleepiness

Sleep Medicine Clinics

Volumn 1, Issue 1, 2006, Pages 127-137

  Iranzo, Alex ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59249102401     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2005.11.003     Document Type: Review

References (84)

1. Rye D., and Iranzo A. The nocturnal manifestations of waking movement disorders: focus on Parkinson's disease. In: Guilleminault C. (Ed). Handbook of clinical neurophysiology, vol. 6. Sleep and its disorders (2005), Elsevier, Philadelphia 263-272
2. Nausieda P.A. Sleep in Parkinson's disease. In: Koller W.C. (Ed). Handbook of Parkinson's disease. 2nd edition (1992), Marcel Dekker, New York 451-467
3. Frucht S., Rogers M.D., Greene P.E., et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52 (1999) 1908-1910
4. Olanow C.W., Schapira A.H.V., and Roth T. Waking up to sleep episodes in Parkinson's disease. Mov Disord 15 (2000) 212-215
5. Frucht S.J., Greene P.E., and Fahn S. Sleep episodes in Parkinson's disease: a wake-up call. Mov Disord 15 (2000) 601-603
6. Tandberg E., Larsen J.P., and Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 14 (1999) 922-927
7. Tan E.K., Lum S.Y., Fook-Chong S.M.C., et al. Evaluation of somnolence in Parkinson's disease: comparison with age and sex-matched controls. Neurology 58 (2002) 465-468
8. Hobson D.E., Lang A.E., Martin W.W.R., et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian movement disorder group. JAMA 287 (2002) 455-463
9. Kumar S., Bhatia M., and Behari M. Sleep disorders in Parkinson's disease. Mov Disord 17 (2002) 775-781
10. Fabbrini G., Barbanti P., Aurilia C., et al. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 17 (2002) 1026-1030
11. O'Suilleabhain P.E., and Dewey R.B. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 59 (2002) 986-989
12. Högl B., Seppi K., Brandauer E., et al. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord 18 (2003) 319-323
13. Brodsky M.A., Godbold J., Roth T., et al. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 18 (2003) 668-672
14. Kumar S., Bhatia M., and Behari M. Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS). Sleep Med 4 (2003) 339-342
15. Furumoto H. Excessive daytime somnolence in Japanese patients with Parkinson's disease. Eur J Neurol 11 (2004) 535-540
16. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 9 (2005) 180-200
17. Meindorfner C., Körner Y., Möller J.C., et al. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 20 (2005) 832-842
18. Santamaria J. How to evaluate excessive daytime sleepiness in Parkinson's disease. Neurology 63 Suppl 3 (2004) S21-S23
19. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
20. Arand D., Bonnet M., Hurwitz T., et al. The clinical use of the MSLT and MWT. Sleep 28 (2005) 123-144
21. Marinus J., Visser M., van Hilten J.J., et al. Assessment of sleep and sleepiness in Parkinson disease. Sleep 26 (2003) 1049-1054
22. Rye D.B., Bliwise D.L., Dihenia B., et al. FAST TRACK. Daytime sleepiness in Parkinson's disease. J Sleep Res 9 (2000) 63-69
23. Arnulf I., Bonnet A.M., Damier P., et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 55 (2000) 281-288
24. Arnulf I., Konofal E., Merino-Andreu M., et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 58 (2002) 1019-1024
25. Roth T., Rye D.B., Borcher L.D., et al. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 4 (2003) 275-280
26. Kaynak D., Kiziltan G., Kaynak H., et al. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 12 (2005) 199-207
27. Chervin R.D., and Aldrich M.S. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 52 (1999) 125-131
28. Razmy A., Lang A.E., and Shapiro C.M. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 61 (2004) 97-102
29. Stevens S., Comella C.L., and Stepanski E.J. Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 27 (2004) 967-972
30. Rye D.B., Johnston L.H., Watts R.L., et al. Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset. Neurology 53 (1999) 1868-1870
31. Daley J., Turner R., Bliwise D., et al. Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 22 Suppl (1999) S218-S219
32. Hauser R.A., Gauger L., McDowell-Anderson W., et al. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 15 (2000) 658-663
33. Montastruc J.L., Brefel-Courbon C., Senard J.M., et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharamacoepidemiologic study. Clin Neurol 24 (2001) 181-183
34. Pal S., Bhattacharya K.F., Agapito C., et al. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 108 (2001) 71-77
35. Möller J.C., Stiasny K., Hargutt V., et al. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord 17 (2002) 474-481
36. Homann C.N., Wenzel K., Suppan K., et al. Sleep attacks in patients taking dopamine agonists: review. BMJ 324 (2002) 1483-1487
37. Paus S., Brecht H.M., Köster J., et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 18 (2003) 659-667
38. Körner Y., Meindorfner C., Möller J.C., et al. Predictors of sudden onset of sleep in Parkinson's disease. Mov Disord 19 (2004) 1298-1305
39. Manni R., Terzaghi M., Sartori I., et al. Dopamine agonist and sleepiness in PD: review of the literature and personal findings. Sleep Med 5 (2004) 189-193
40. Avorn J., Scneeweiss S., Sudarsky L.R., et al. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol 62 (2005) 1242-1248
41. Schapira A.H.V. Sleep attacks (sleep episodes) with pergolide. Lancet 355 (2000) 1332-1333
42. Ferreira J.J., Galitzky M., Montastruc J.L., et al. Sleep attacks and Parkinson's disease treatment. Lancet 355 (2000) 1333-1334
43. Merino-Andreu M., Arnulf I., Konofal E., et al. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology 60 (2003) 1553-1554
44. Schlesinger I., and Ravin P.D. Dopamine agonists induce episodes of irresistible daytime sleepiness. Eur Neurol 49 (2003) 30-33
45. Garcia-Borreguero D., Schwarz C., Larrosa O., et al. L-DOPA-induce excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. Neurology 61 (2003) 1008-1010
46. Homann C.N., Homann B., Ott E., et al. Sleep attacks may not be a side-effect dopaminergic medication. Mov Disord 18 (2003) 1569-1571
47. Ferreira J.J., Thalamas C., Montastruc J.L., et al. Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients. J Neurol 248 (2001) 426-427
48. Jimenez-Jimenez F.J., Velasco I., Toledo M., et al. Multiple latency test in a patient with episodes of sleep induced by pergolide. Rev Neurol (Barc) 34 (2002) 1140-1141
49. Bares M., Kanovsky P., and Rektor I. Excessive daytime sleepiness and "sleep attacks" induced by entacapone. Fundam Clin Pharmacol 17 (2003) 113-116
50. Santens P. Sleep attacks in Parkinson's disease induced by entacapone, a COMT-inhibitor. Fundam Clin Pharmacol 17 (2003) 121-123
51. Tracik F., and Ebersbach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. Mov Disord 16 (2001) 500-506
52. Ebersbach G., Norden J., and Tracik F. Sleep attacks in Parkinson's disease: polysomnographic recordings. Mov Disord 15 Suppl 3 (2000) 89
53. Schäfer D., and Greulich W. Effects of parkinsonian medication on sleep. J Neurol 247 Suppl 4 (2000) 24-27
54. Romigi A., Brusa L., Marciani M.G., et al. Sleep episodes and daytime somnolence as a result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. J Neurol Sci 228 (2005) 7-10
55. Ulivelli M., Rossi S., Lombardi C., et al. Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology 58 (2002) 462-465
56. Rye D.B., and Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58 (2002) 341-346
57. Rye D.B. The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 63 Suppl 3 (2004) S2-S7
58. Ondo W.G., Dat Vuong K., Khan H., et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57 (2001) 1392-1396
59. Frauscher B., Höghl B., Maret S., et al. Association of daytime sleepiness with COMT polymorphism in patients with Parkinson disease: a pilot study. Sleep 27 (2004) 733-736
60. Happe S., Berguer K., and on behalf of the FAQT study investigators. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease: a prospective study. J Neurol 248 (2001) 1062-1067
61. Gjerstad M.D., Aarsland D., and Larsen J.P. Development of daytime somnolence over time in Parkinson's disease. Neurology 58 (2002) 1544-1546
62. Fabbrini G., Barbanti P., Aurilia C., et al. Excessive daytime somnolence in Parkinson's disease: follow-up after 1 year of treatment. Neurol Sci 24 (2003) 178-179
63. Freeman A., Ciliax B., Bakay R., et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 50 (2001) 321-329
64. Jellinger K.A. Post mortem studies in Parkinson's disease: is it possible to detect brain areas for specific symptoms?. J Neural Transm Suppl 56 (1999) 1-29
65. Overeem S., van Hilten J.J., Ripley B., et al. Normal hypocretin-1 levels in Parkinson's disease with excessive daytime sleepiness. Neurology 58 (2002) 498-499
66. Baumann C., Ferini-Strambi L., Waldvogel D., et al. Parkinsonism with excessive daytime sleepiness: a narcolepsy-like disorder?. J Neurol 252 (2005) 139-145
67. Drouot X., Moutereau S., Nguyen J.P., et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61 (2003) 540-543
68. Vincken W.G., Gauthier S.G., Dollfuss R.E., et al. Involvement of upper-airway muscles in extrapyramidal disorders. N Engl J Med 311 (1984) 438-442
69. Braga-Neto P., Pereira da Sila-Junior F., Sueli Monte F., et al. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 217 (2004) 41-45
70. Martin S.E., Mathur R., Marshall I., et al. The effect of age, sex, obesity and posture on upper airway size. Eur Respir J 10 (1997) 2087-2090
71. Anconi-Israel S., Kripke D.F., Klauber M.R., et al. Sleep-disordered breathing in community-dwelling elderly. Sleep 14 (1991) 486-495
72. Bittinger L.J., McNear K.K., Khan F., et al. Obstructive sleep apnea on polysomnography in patients with parkinsonism. Sleep 28 (2005) A283
73. Hitchcock S.E., Greer S.A., Pour Ansari F., et al. Sleep disordered breathing (SDB) in Parkinsons disease (PD). Sleep 28 (2005) A286-A287
74. Diederich N.J., Vaillant M., Leischen M., et al. Sleep apnea syndrome in Parkinson's disease: a case-control study in 49 patients. Mov Disord 11 (2005) 1413-1418
75. Contin M., Provini F., Martinelli P., et al. Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoring. Clin Neuropharmacol 26 (2003) 115-118
76. Paus S., Seeger G., Brecht H.M., et al. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease. Mov Disord 19 (2004) 705-707
77. Rissling I., Geller F., Bandmann O., et al. Dopamine gene receptor gene polymorphisms in Parkinson's disease patients reporting sleep attacks. Mov Disord 19 (2004) 1279-1284
78. Rissling I., Köner Y., Geller F., et al. Prehypocretin polymorphysms in Parkinson disease patients reporting sleep attacks. Sleep 28 (2005) 871-875
79. Barone P., Amboni M., Vitale C., et al. Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. Neurology 63 Suppl 3 (2004) S35-S38
80. Del Dotto P., Gambaccini G., Caneparo D., et al. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists. Neurol Sci 24 (2003) 170-171
81. Hauser R.A., Wahba M.N., Zesiewicz T.A., et al. Modafinil treatment of pramipexole-associated somnolence. Mov Disord 15 (2000) 1269-1271
82. Högl B., Saletu M., Brandauer E., et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25 (2002) 905-909
83. Adler C.H., Caviness J.N., Hentz J.G., et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 18 (2003) 287-293
84. Nieves A.V., and Lang A.E. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clin Neuropharmacol 25 (2002) 111-114